Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome

被引:40
|
作者
Douchi, T [1 ]
Oki, T [1 ]
Yamasaki, H [1 ]
Kuwahata, R [1 ]
Nakae, M [1 ]
Nagata, Y [1 ]
机构
[1] Kagoshima Univ, Dept Obstet & Gynecol, Fac Med, Kagoshima 8908520, Japan
来源
OBSTETRICS AND GYNECOLOGY | 2001年 / 98卷 / 03期
关键词
D O I
10.1016/S0029-7844(01)01450-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To investigate the relationship of androgens to regional muscle size and bone mineral density (BMD) in women with polycystic ovary syndrome (PCOS). METHODS: Seventy-one amenorrheic and right-side dominant women with PCOS (mean age +/- standard deviation 28.1 +/- 6.7 years) were enrolled. Baseline characteristics included age, height, weight, and body mass index (BMI). Regional BAM and lean mass were measured by whole-body scanning with dual-energy x-ray absorptiometry. Serum levels of testosterone, dehydroepiandrosterone sulfate (DHEAS), and androstenedione were measured by radioimmunoassay. Correlations between regional BMD and variables were investigated using a Pearson correlation test and multiple regression analysis. RESULTS: Serum testosterone levels correlated significantly with lean mass of the left arm, right arm, trunk, left leg, and right leg (r = .34, P < .05 to r = .50, P < .01). Regional lean mass correlated significantly with respective regional BMD (r = .30, P < .05 to r = .68, P < .001). These relationships remained significant after adjusting for age, height, and weight. Serum testosterone levels were not correlated with BAM of the bilateral arms and lumbar spine. Although serum testosterone levels correlated with leg BMD (r = .34, P < .05 to r = .45, P < .01), significance did not persist after adjusting for respective regional lean mass. CONCLUSION: Testosterone influences regional BMD through increasing regional muscle mass in women with polycystic ovary syndrome. (C) 2001 by the American College of Obstetricians and Gynecologists.
引用
收藏
页码:445 / 449
页数:5
相关论文
共 50 条
  • [41] The effect of circulating androgens on bone mineral density in postmenopausal women
    Tok, EC
    Ertunc, D
    Oz, U
    Camdeviren, H
    Ozdemir, G
    Dilek, S
    MATURITAS, 2004, 48 (03) : 235 - 242
  • [42] Effects of antiandrogen therapy on bone mineral density and plasma amylin levels in patients with polycystic ovary syndrome*
    Ueckaya, G.
    Bolu, S. E.
    Kutlu, M.
    Yazici, M.
    Azal, O.
    Beyhan, Z.
    Oezguertas, T.
    Arslan, N.
    Emer, T.
    Corakci, A.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S325 - S325
  • [43] Relationship of femoral neck areal bone mineral density to volumetric bone mineral density, bone size, and femoral strength in men and women
    Srinivasan, B.
    Kopperdahl, D. L.
    Amin, S.
    Atkinson, E. J.
    Camp, J.
    Robb, R. A.
    Riggs, B. L.
    Orwoll, E. S.
    Melton, L. J., III
    Keaveny, T. M.
    Khosla, S.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 (01) : 155 - 162
  • [44] The role of androgens in microvascular endothelial dysfunction in polycystic ovary syndrome: does size matter?
    Moreau, Kerrie L.
    DuBose, Lyndsey E.
    JOURNAL OF PHYSIOLOGY-LONDON, 2019, 597 (11): : 2829 - 2830
  • [45] Relationship of femoral neck areal bone mineral density to volumetric bone mineral density, bone size, and femoral strength in men and women
    B. Srinivasan
    D. L. Kopperdahl
    S. Amin
    E. J. Atkinson
    J. Camp
    R. A. Robb
    B. L. Riggs
    E. S. Orwoll
    L. J. Melton
    T. M. Keaveny
    S. Khosla
    Osteoporosis International, 2012, 23 : 155 - 162
  • [46] Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome
    Tziomalos, Konstantinos
    Katsikis, Ilias
    Papadakis, Efstathios
    Kandaraki, Eleni A.
    Macut, Djuro
    Panidis, Dimitrios
    HUMAN REPRODUCTION, 2013, 28 (03) : 785 - 793
  • [47] Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome
    McDonnell, Tara
    Cussen, Leanne
    McIlroy, Marie
    O'Reilly, Michael W.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2022, 13
  • [48] Pelvic floor muscle thickness in women with polycystic ovary syndrome
    Vieira de Melo, M. H.
    Barbosa Cabral Micussi, M. T. Albuquerque
    Dias de Medeiros, R.
    Ney Cobucci, R.
    de Oliveira Maranhao, T. M.
    Goncalves, A. K.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2018, 45 (06): : 813 - 816
  • [49] Differential Effects of Various Androgens on Polycystic Ovary Syndrome
    de Medeiros, Sebastiao Freitas
    Barbosa, Bruna Barcelo
    Winck Yamamoto de Medeiros, Ana Karine Lin
    Souto de Medeiros, Matheus Antonio
    Winck Yamamoto, Marcia Marly
    HORMONE AND METABOLIC RESEARCH, 2021, 53 (05) : 341 - 349
  • [50] Bone mineral density and uterine size. A practical relationship for climacteric women
    Porcile, A
    Gallardo, E
    Duarte, P
    REVISTA MEDICA DE CHILE, 2000, 128 (10) : 1127 - 1131